India's Alkem Laboratories rises after GST demand relief order
** Shares of India's Alkem Laboratories ALKE.NS up 3.89% at 5,614.5 rupees ** The pharmaceutical firm received a favourable Order-in-Appeal from a statutory authority, that dropped a GST demand of 696.6 million rupees ($7.33 million) ** Company sees no material impact on its financials, operation or other activities ** ALKE stock rated "buy" on avg by 17 analysts; median PT:5890 rupees - LSEG-compiled data ** YTD, Alkem stock down 1.88% ($1 = 95.0725 Indian rupees) (Reporting by Devika Nair in Bengaluru) ((Devika.MadhusudhananNair@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees